To Evaluate the Performance and Efficiency of Robotic Surgery in Children and Adults (PECRoP)
Robotic minimally invasive surgery has been rapidly adopted for a wide variety of surgical procedures in adult patients across a broad spectrum of surgical specialties. This has occurred despite the high costs and uncertain benefits of surgical robots.
In contrast, Children's Hospitals and pediatric surgical disciplines have been much slower to embrace the surgical robot. Many children's hospitals do not even possess a surgical robot, and many of those that do borrow them from the adult operating room within the same medical facility.
Since the first case of robotic minimally invasive surgery in children in 2000, robotic procedures have been slowly adopted by select pediatric surgical specialists.
Advocates of robotic minimally invasive surgical systems add many useful features that include improved dexterity, motion scaling, tremor filtration, greater optical magnification (up to 10x), stereoscopic vision, operator-controlled camera movement, and the elimination of the fulcrum effect when compared to conventional laparoscopy. The wristed laparoscopic instruments used in robotic surgery provide seven degrees of freedom.
For the surgeon, these features may allow for more precise dissection with increased magnification and visibility. The intuitive controls of the robot are purported as providing the ability to perform laparoscopic procedures in an "open" fashion. In pediatric surgical procedures, these technical abilities may have the potential to surpass the physical capabilities of human performance in the tight operative fields encountered in children.
This study aims to evaluate the clinical safety, effectiveness, and cost-effectiveness of robot-assisted minimally invasive surgery in both pediatric and adult patients. Robotic surgery was developed to overcome key limitations of conventional laparoscopy, including 2D visualization, limited instrument mobility, poor ergonomics, and long learning curves. The trial will assess clinical outcomes, postoperative pain, length of stay, return to daily activities, access to minimally invasive surgery, and the impact of robotic surgery on surgical training. Specific indications, such as pyeloplasty, will also be compared with open and conventional laparoscopic approaches.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Minimally invasive surgery (MIS) has transformed surgical practice since the 1980s, offering reduced postoperative pain, shorter hospitalization, faster recovery, and improved cosmetic outcomes. However, conventional laparoscopy is limited by rigid instruments, 2D imaging, non-intuitive motion, and challenging ergonomics, resulting in long learning curves, especially in pediatric surgery where operative spaces are smaller.
Robot-assisted surgery, introduced in 1999 with the Da Vinci system, was designed to overcome these limitations by providing 3D high-definition visualization, articulated instruments with seven degrees of freedom, tremor filtration, intuitive movements, surgeon-controlled camera operation, and improved ergonomics. Its dual-console configuration also enhances surgical training.
Despite widespread adoption in adults, pediatric use remains limited. This multicenter study will evaluate robot-assisted surgery across several specialties (urology, gynecology, visceral surgery, thoracic surgery, pediatric surgery, and ENT), in accordance with CE-marked indications.
The study will assess:
clinical outcomes and quality of life, postoperative pain, length of stay, and return to daily activities, access to MIS for patients with comorbidities or complex multidisciplinary needs, reduction of the learning curve compared with laparoscopy, benefits for resident and fellow training, and, for pyeloplasty, comparison with open and laparoscopic techniques. Interim analyses will be performed and may generate hypotheses for future research.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Thomas Blanc, MD, PhD
- Phone Number: 01 44 49 41 53
- Email: thomas.blanc@aphp.fr
Study Contact Backup
- Name: Sarah BOUCHARD
- Phone Number: 01 42 19 28 79
- Email: solimda.sotoubere@aphp.fr
Study Locations
-
-
Paris
-
Paris, Paris, France, 75015
- Recruiting
- Hôpital Necker -Enfants Malades
-
Contact:
- Thomas Blanc, MD, PhD
- Phone Number: 01 44 49 41 53
- Email: thomas.blanc@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria :
- child or adult
- with an indication for a robotic surgery
- non-opposition of patient or non-opposition of parents for minor patient
Exclusion Criteria :
- anatomic or anesthetic contraindication for the mini-invasive surgery
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Other
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
patient group
Surgery with robot - all patients operated in surgery department with indication of robot in the routine care (all specialities).
|
|
control group
Retroperitoneal coelioscopy - patient operated for pyeloplasty - only for pediatry
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Per and post-surgery complication
Time Frame: 6 months
|
per and post-surgery complication (Clavien-Dindo score)
|
6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-surgery pain with analgesic prescription
Time Frame: 6 months
|
6 months
|
|
|
Resection quality (R0) of oncologic surgery
Time Frame: 6 months
|
6 months
|
|
|
Functional results according to the surgery indication
Time Frame: 6 months
|
6 months
|
|
|
Frequency and percentage of intervention with robot in each speciality
Time Frame: 6 months
|
6 months
|
|
|
Duration of activity of the operating block
Time Frame: 6 months
|
6 months
|
|
|
Average duration of anaesthesia
Time Frame: 6 months
|
6 months
|
|
|
Average duration of robotic surgery and docking
Time Frame: 6 months
|
6 months
|
|
|
Duration of intervention by speciality (learning curve)
Time Frame: 6 months
|
6 months
|
|
|
Frequency and percentage of conversion to open-procedure
Time Frame: 6 months
|
6 months
|
|
|
Post surgery pain (Evendol pain scale)
Time Frame: 6 months
|
6 months
|
|
|
Prescription of analgesic
Time Frame: 6 months
|
6 months
|
|
|
Duration of hospitalization
Time Frame: 6 months
|
6 months
|
|
|
Cost of robotic surgery by indication, tools and supplies
Time Frame: 6 months
|
6 months
|
|
|
Duration of post surgery work stoppage (activ patient)
Time Frame: 6 months
|
6 months
|
|
|
Duration before returning to normal activity (other patient)
Time Frame: 6 months
|
6 months
|
|
|
Difference in average costs per patients (in €) divided by the difference in post operative complications using the Clavien Dindo scale
Time Frame: 6 months
|
6 months
|
|
|
Quality of life (SF-36)
Time Frame: At the inclusion visit (baseline) and 6 months
|
36-items Short Form health survey
|
At the inclusion visit (baseline) and 6 months
|
|
Health survey (EQ-5D-5L)
Time Frame: At the inclusion visit (baseline) and 6 months
|
Each dimension in the EQ-5D-5L has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5)
|
At the inclusion visit (baseline) and 6 months
|
|
The Saint-George's hospital Respiratory Questionnaire (SGRQ)
Time Frame: At the inclusion visit (baseline) and 6 months
|
0 indicates best health and 100 indicates worst health
|
At the inclusion visit (baseline) and 6 months
|
|
Patient Global Impression of Improvement (PGI-I)
Time Frame: At the inclusion visit (baseline) and 6 months
|
1-question assessment designed to evaluate the patient's impression of improvement since surgery- PGI-I score: 1 = very much better; 2 = much better; 3 = a little better; 4 = no change; 5 = a little worse; 6 = much worse; 7 = very much worse
|
At the inclusion visit (baseline) and 6 months
|
|
Female Sexual Function Index (FSFI)
Time Frame: At the inclusion visit (baseline) and 6 months
|
The FSFI is a validated 19-item self-administered questionnaire assessing female sexual function across six domains (desire, arousal, lubrication, orgasm, satisfaction, and pain) during the previous 4 weeks.
Domain scores are weighted according to the FSFI scoring algorithm and summed to generate a total score ranging from 2 to 36, with higher scores indicating better sexual function.
|
At the inclusion visit (baseline) and 6 months
|
|
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 (PISQ-12)
Time Frame: At the inclusion visit (baseline) and 6 months
|
The PISQ-12 is a validated, disease-specific, self-administered questionnaire designed to assess sexual function in women with pelvic organ prolapse and/or urinary incontinence.
The questionnaire consists of 12 items evaluating three domains: behavioral-emotive aspects, physical factors, and partner-related factors affecting sexual function.
Responses are summed to generate a total score, with higher scores indicating better sexual function.
|
At the inclusion visit (baseline) and 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Thomas BLANC, MD; PhD, Assistance Publique - Hôpitaux de Paris
- Study Chair: Morgane ROUPRET, MD, PhD, Assistance Publique - Hôpitaux de Paris
Publications and helpful links
General Publications
- Harte C, Ren M, Querciagrossa S, Druot E, Vatta F, Sarnacki S, Dahmani S, Orliaguet G, Blanc T. Anaesthesia management during paediatric robotic surgery: preliminary results from a single centre multidisciplinary experience. Anaesth Crit Care Pain Med. 2021 Jun;40(3):100837. doi: 10.1016/j.accpm.2021.100837. Epub 2021 Mar 20.
- Franzini S, Querciagrossa S, Brebion M, Consonni D, Blanc T, Orliaguet G. Effect of retropneumoperitoneum on cerebral and renal oxygen saturation during retroperitoneal robotic-assisted laparoscopic pyeloplasty (R-RALP) in a pediatric population: Preliminary results of a prospective observational study using a dedicated anesthetic protocol and Near-InfraRed Spectroscopy. Anaesth Crit Care Pain Med. 2023 Oct;42(5):101234. doi: 10.1016/j.accpm.2023.101234. Epub 2023 Apr 28.
- Vinit N, Vatta F, Broch A, Hidalgo M, Kohaut J, Querciagrossa S, Couloigner V, Khen-Dunlop N, Botto N, Capito C, Sarnacki S, Blanc T. Adverse Events and Morbidity in a Multidisciplinary Pediatric Robotic Surgery Program. A prospective, Observational Study. Ann Surg. 2023 Nov 1;278(5):e932-e938. doi: 10.1097/SLA.0000000000005808. Epub 2023 Jan 23.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- NI16026J
- 2017-A01507-46 (Other Identifier: IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.